These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


259 related items for PubMed ID: 26667313

  • 1. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women.
    Bruijn M, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers H, Spaanderman M, Bloemenkamp K, Haak MC, Bolte AC, Vandenbussche F, Woiski MD, Bax CJ, Cornette J, Duvekot JJ, Nij Bijvanck B, van Eyck J, Franssen M, Sollie KM, van der Post J, Bossuyt P, Opmeer BC, Kok M, Mol B, van Baaren GJ.
    BJOG; 2016 Nov; 123(12):1965-1971. PubMed ID: 26667313
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the ability of cervical length and fetal fibronectin measurement to predict preterm delivery in asymptomatic women with risk factors.
    Zhou MX, Zhou J, Bao Y, Chen YQ, Cai C.
    J Matern Fetal Neonatal Med; 2015 Jan; 28(2):153-7. PubMed ID: 24678648
    [Abstract] [Full Text] [Related]

  • 3. The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women.
    Bruijn MM, Kamphuis EI, Hoesli IM, Martinez de Tejada B, Loccufier AR, Kühnert M, Helmer H, Franz M, Porath MM, Oudijk MA, Jacquemyn Y, Schulzke SM, Vetter G, Hoste G, Vis JY, Kok M, Mol BW, van Baaren GJ.
    Am J Obstet Gynecol; 2016 Dec; 215(6):793.e1-793.e8. PubMed ID: 27542720
    [Abstract] [Full Text] [Related]

  • 4. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study.
    Levine LD, Downes KL, Romero JA, Pappas H, Elovitz MA.
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers HC, Spaanderman ME, Bloemenkamp KW, Haak MC, Bolte AC, Vandenbussche FP, Woiski MD, Bax CJ, Cornette JM, Duvekot JJ, Nij Bijvank BW, van Eyck J, Franssen MT, Sollie KM, van der Post JA, Bossuyt PM, Opmeer BC, Kok M, Mol BW, van Baaren GJ.
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY, Lee JY, Kim HM, Kim MJ, Cha HH, Seong WJ.
    BMC Pregnancy Childbirth; 2019 Jul 11; 19(1):241. PubMed ID: 31296172
    [Abstract] [Full Text] [Related]

  • 7. The value of quantitative ultrasound tissue characterization of the cervix and rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I, Wallwiener D, Schmidt S.
    J Perinat Med; 2005 Jul 11; 33(5):383-91. PubMed ID: 16238532
    [Abstract] [Full Text] [Related]

  • 8. Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days.
    Hermans FJR, Bruijn MMC, Vis JY, Wilms FF, Oudijk MA, Porath MM, Scheepers HCJ, Bloemenkamp KWM, Bax CJ, Cornette JMJ, Nij Bijvanck BWA, Franssen MTM, Vandenbussche FPHA, Kok M, Grobman WA, Van Der Post JAM, Bossuyt PMM, Opmeer BC, Mol BWJ, Schuit E, Van Baaren GJ.
    Acta Obstet Gynecol Scand; 2015 Jul 11; 94(7):715-721. PubMed ID: 25845495
    [Abstract] [Full Text] [Related]

  • 9. Significance of cervical gland area in predicting preterm birth for patients with threatened preterm delivery: comparison with cervical length and fetal fibronectin.
    Asakura H, Fukami T, Kurashina R, Tateyama N, Doi D, Takeshita T.
    Gynecol Obstet Invest; 2009 Jul 11; 68(1):1-8. PubMed ID: 19321961
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for preterm delivery: do they add to fetal fibronectin testing and cervical length measurement in the prediction of preterm delivery in symptomatic women?
    van Baaren GJ, Bruijn MM, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers HC, Spaanderman ME, Bloemenkamp KW, Haak MC, Bolte AC, Bax CJ, Cornette JM, Duvekot JJ, Nij Bijvanck BW, van Eijck J, Franssen MT, Sollie KM, Vandenbussche FP, Woiski M, Bossuyt PM, Opmeer BC, Mol BW.
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep 11; 192():79-85. PubMed ID: 26182836
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor.
    van Baaren GJ, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Scheepers HCJ, Spaanderman MEA, Bloemenkamp KWM, Haak MC, Bax CJ, Cornette JMJ, Duvekot JJ, Nij Bijvanck BWA, van Eyck J, Franssen MTM, Sollie KM, Vandenbussche FPHA, Woiski M, Bolte AC, van der Post JAM, Bossuyt PMM, Opmeer BC, Mol BWJ.
    Ultrasound Obstet Gynecol; 2018 May 11; 51(5):596-603. PubMed ID: 28370518
    [Abstract] [Full Text] [Related]

  • 12. Utility of cervical length and quantitative fetal fibronectin for predicting spontaneous preterm delivery among symptomatic nulliparous women.
    Kyozuka H, Murata T, Sato T, Suzuki S, Yamaguchi A, Fujimori K.
    Int J Gynaecol Obstet; 2019 Jun 11; 145(3):331-336. PubMed ID: 30941761
    [Abstract] [Full Text] [Related]

  • 13. Prediction of preterm delivery by fetal fibronectin in symptomatic and asymptomatic women with cervical length ≤20 mm.
    Magro-Malosso E, Seravalli V, Cozzolino M, Spitaleri M, Susini T, Di Tommaso M.
    J Matern Fetal Neonatal Med; 2017 Feb 11; 30(3):294-297. PubMed ID: 27052846
    [Abstract] [Full Text] [Related]

  • 14. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC, Navas H, Marcos M, Iza A, De Diego M, Rando D, Melchor I, Burgos J.
    Ultrasound Obstet Gynecol; 2018 May 11; 51(5):644-649. PubMed ID: 28850753
    [Abstract] [Full Text] [Related]

  • 15. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour.
    Audibert F, Fortin S, Delvin E, Djemli A, Brunet S, Dubé J, Fraser WD.
    J Obstet Gynaecol Can; 2010 Apr 11; 32(4):307-12. PubMed ID: 20500936
    [Abstract] [Full Text] [Related]

  • 16. What is the risk of preterm delivery after arrested preterm labor?
    Wilms FF, Vis JY, de Wit-Zuurendonk L, Porath MM, Mol BW.
    Am J Perinatol; 2015 Jan 11; 32(1):63-70. PubMed ID: 24839150
    [Abstract] [Full Text] [Related]

  • 17. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor.
    Nikolova T, Bayev O, Nikolova N, Di Renzo GC.
    J Perinat Med; 2015 Jul 11; 43(4):395-402. PubMed ID: 25562603
    [Abstract] [Full Text] [Related]

  • 18. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery.
    Ng VWY, Seto MTY, Lewis H, Cheung KW.
    BMC Pregnancy Childbirth; 2023 Apr 04; 23(1):225. PubMed ID: 37016314
    [Abstract] [Full Text] [Related]

  • 19. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M, Ghidini A, Korker V, Pezzullo JC.
    Arch Gynecol Obstet; 2007 May 04; 275(5):347-51. PubMed ID: 17051404
    [Abstract] [Full Text] [Related]

  • 20. The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis.
    Boots AB, Sanchez-Ramos L, Bowers DM, Kaunitz AM, Zamora J, Schlattmann P.
    Am J Obstet Gynecol; 2014 Jan 04; 210(1):54.e1-54.e10. PubMed ID: 24021995
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.